GIM
Granahan Investment Management Portfolio holdings
AUM
$2.46B
This Quarter Return
-23.11%
1 Year Return
+66.36%
3 Year Return
+183.04%
5 Year Return
+309.49%
10 Year Return
+1,968.52%
AUM
$2.93B
AUM Growth
+$2.93B
(-27%)
Cap. Flow
-$26.5M
Cap. Flow
% of AUM
-0.9%
Top 10 Holdings %
Top 10 Hldgs %
32.29%
Holding
195
New
17
Increased
84
Reduced
71
Closed
23
Top Buys
| 1 |
Toast
TOST
|
$44.9M |
| 2 |
Paylocity
PCTY
|
$31.9M |
| 3 |
Kornit Digital
KRNT
|
$20.5M |
| 4 |
Array Technologies
ARRY
|
$16.7M |
| 5 |
FIGS
FIGS
|
$16.5M |
Top Sells
| 1 |
Evolent Health
EVH
|
$41.3M |
| 2 |
Chegg
CHGG
|
$40.8M |
| 3 |
MSP
Datto Holding Corp.
MSP
|
$36.9M |
| 4 |
BBBY
Bed Bath & Beyond, Inc.
BBBY
|
$35.3M |
| 5 |
Chart Industries
GTLS
|
$19M |
Sector Composition
| 1 | Technology | 39.58% |
| 2 | Healthcare | 20.5% |
| 3 | Industrials | 13.17% |
| 4 | Consumer Discretionary | 10.74% |
| 5 | Communication Services | 5.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
American Well
AMWL
$112M
| $7.07M | 0.24% |
1,636,424
-51,080
| -3% | -$221K |
|
102
Fate Therapeutics
FATE
$115M
| $6.52M | 0.22% |
263,156
+58,211
| +28% | +$1.44M |
|
103
Apellis Pharmaceuticals
APLS
$3.51B
| $6.4M | 0.22% |
141,592
-12,331
| -8% | -$558K |
|
104
Arcus Biosciences
RCUS
$1.23B
| $6.35M | 0.22% |
250,385
+24,335
| +11% | +$617K |
|
105
Ciena
CIEN
$13.4B
| $6.28M | 0.21% |
137,349
+13,017
| +10% | +$595K |
|
106
PAR Technology
PAR
$1.99B
| $6.07M | 0.21% |
+161,770
| New | +$6.07M |
|
|
HSKA
107
DELISTED
Heska Corp
HSKA
| $6.02M | 0.21% |
63,653
+22,504
| +55% | +$2.13M |
|
108
Kinsale Capital Group
KNSL
$10.5B
| $5.91M | 0.2% |
25,718
-18,951
| -42% | -$4.35M |
|
109
Onto Innovation
ONTO
$5B
| $5.9M | 0.2% |
84,546
-1,300
| -2% | -$90.7K |
|
110
PTC
PTC
$25.4B
| $5.83M | 0.2% |
54,865
-900
| -2% | -$95.7K |
|
111
AXT Inc
AXTI
$142M
| $5.69M | 0.19% |
971,340
+23,439
| +2% | +$137K |
|
112
Qualys
QLYS
$4.9B
| $5.62M | 0.19% |
44,589
-3,044
| -6% | -$384K |
|
113
Harvard Bioscience
HBIO
$21.1M
| $5.52M | 0.19% |
1,532,693
+75,944
| +5% | +$273K |
|
114
Revolve Group
RVLV
$1.6B
| $5.5M | 0.19% |
212,240
-169,280
| -44% | -$4.39M |
|
|
AERI
115
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $5.31M | 0.18% |
707,398
-881,546
| -55% | -$6.61M |
|
116
Hudson Technologies
HDSN
$446M
| $5.26M | 0.18% |
700,896
-550,079
| -44% | -$4.13M |
|
|
BPMC
117
DELISTED
Blueprint Medicines
BPMC
| $5.24M | 0.18% |
103,646
-53,000
| -34% | -$2.68M |
|
118
Organogenesis Holdings
ORGO
$629M
| $4.84M | 0.17% |
991,980
-989,783
| -50% | -$4.83M |
|
119
Portillo's
PTLO
$488M
| $4.77M | 0.16% |
291,710
-37,626
| -11% | -$615K |
|
120
Silicon Laboratories
SLAB
$4.27B
| $4.63M | 0.16% |
33,028
+341
| +1% | +$47.8K |
|
121
Xencor
XNCR
$593M
| $4.62M | 0.16% |
168,962
-26,376
| -14% | -$722K |
|
122
InMode
INMD
$916M
| $4.54M | 0.16% |
202,579
-270,599
| -57% | -$6.06M |
|
123
Harmonic Inc
HLIT
$1.11B
| $4.48M | 0.15% |
516,471
+52,503
| +11% | +$455K |
|
124
Littelfuse
LFUS
$6.27B
| $4.36M | 0.15% |
+17,144
| New | +$4.36M |
|
125
AtriCure
ATRC
$1.73B
| $4.34M | 0.15% |
106,271
+7,660
| +8% | +$313K |
|